Key advisor: FDA should hold diabetes drugs to different standard
In an opinion piece yesterday, the chair of the FDA advisory committee on Avandia recommended the agency change the way it evaluates experimental diabetes drugs.
Your Email Address:
Recipient(s) Email Address:
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Include a message (optional):
The e-mail address(es) that you supply to use this service will only be used to send the requested article.